Delivery Order SPE2DB20D1109-SPE2DB25FP44E
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $14,758.51 to AmerisourceBergen Drug Corp for the supply of Vivitrol 380 mg vial-diluents, with an ultimate completion date of July 23, 2025. This competitively awarded, firm fixed-price delivery order was issued with no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a child contract under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency (DLA) awarded a $4,004.68 delivery order to AmerisourceBergen Drug Corp for the supply of Vivitrol 380 mg vial-diluents, with performance based in Conshohocken, Pennsylvania and completion targeted for July 28, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and represents a routine pharmaceutical procurement supporting federal medical supply requirements. AmerisourceBergen Drug Corp, a major pharmaceutical distributor...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 23, 2025, for the supply of Vivitrol 380 mg vials with diluents, valued at $6,007.02. This competitively awarded, non-set-aside contract employs firm fixed-price pricing and is classified as a delivery order, with an ultimate completion date of July 24, 2025. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is a child contract...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, to supply 380 mg vials of Vivitrol, a medication used to treat opioid dependence. The contract is a firm-fixed price delivery order with a ceiling value of $16,058.67 and a performance period ending on September 5, 2024. AmerisourceBergen has been awarded multiple indefinite-delivery contracts (IDCs) with the DLA and other federal agencies to provide...
- The U.S. Department of Defense's Defense Logistics Agency awarded a firm fixed price delivery order to AmerisourceBergen Drug Corp, a subsidiary of the for-profit pharmaceutical distribution company AmerisourceBergen Corporation, to provide VIVITROL 380 mg vials and diluents. The $4,053.06 order has a completion date of February 6, 2024 and was issued under AmerisourceBergen's existing indefinite delivery contract with DLA Troop Support Medical, which has a potential value of $999,999,999.00 and...
- The Defense Logistics Agency awarded a $8,973.60 firm fixed price delivery order to Amerisourcebergen Drug Corporation for VIVITROL 380 MG VIAL-DILUENTS. Amerisourcebergen Drug Corporation, a division of Amerisourcebergen Corporation, will deliver the requested pharmaceutical products from its facility in Conshohocken, Pennsylvania to support the Defense Logistics Agency's medical supply needs. No major subcontractors or set aside designations were identified. The delivery order was issued on...
- The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a firm-fixed-price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, to provide 380 mg VIVITROL vials and diluents. The $2,798.10 contract has a completion date of February 1, 2024. AmerisourceBergen Drug Corp, a for-profit organization, serves as the prime contractor on this delivery order, which is not associated with any set-aside program. This award is part of a larger...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,904.41 firm fixed-price delivery order is for the supply of VIVITROL 380 MG VIAL-DILUENTS, a medication used in the treatment of alcohol and opioid dependence. The contract has an ultimate completion date of January 14, 2025. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA...
- The Defense Logistics Agency awarded a $4,257 delivery order to Amerisourcebergen Drug Corporation for 380 mg vials of Vivitrol and associated diluents. As the prime contractor, Amerisourcebergen will deliver the pharmaceutical products to a location in Conshohocken, Pennsylvania by September 25, 2023 to fulfill requirements under the agency's logistics and procurement programs. No subcontractors or set aside designations were indicated. The order was placed using firm fixed price terms to a...
- The U.S. Defense Logistics Agency (DLA) awarded a delivery order contract valued at $5,589.11 to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of 4565057997 Vivitrol 380 mg vials and diluents. This delivery order is part of a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with DLA Troop Support Medical, valued up to $999,999,999.00 through December 31, 2025. Under this IDC, Amerisourcebergen provides a comprehensive range of pharmaceutical...
- SPE2DB20D1109Indefinite Delivery Contract
- SPE2DB20D1109-SPE2DB25FP44EDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $3,003.51 to AmerisourceBergen Drug Corp for Vivitrol 380 mg vial-diluents, with an ultimate completion date of July 24, 2025. This competitively awarded, firm fixed-price contract was executed on July 23, 2025, with performance taking place at the vendor's corporate office location in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, a $999.99 billion pharmaceutical support vehicle that runs through December 2026 and enables the company to supply pharmaceuticals and medical supplies to military healthcare programs globally. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical federal medical procurement vendor, serves the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems through its DLA contracts. The company maintains an extensive portfolio of pharmaceutical products across multiple therapeutic domains, including specialty medications, brand-name and generic drugs, vaccines, and medical supplies. This particular delivery order for Vivitrol, an opioid dependence treatment medication, reflects the company's role in supporting military and federal health system requirements without set-aside provisions, demonstrating its competitive standing in open federal procurement.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.0k | 7/23/25 |